CD274 and neoplasm: Next, we went on to examine the synergistic anti-tumor immunotherapy effect of our TTAP system in conjunction with the checkpoint blockade PD-L1 anti-body (α-PD-L1) in a bilateral model of 4T1 tumor-bearing BALB/c mice24,25.